It looks like the marketing and branding campaign by Herbalife is paying off, at least with the stock market. Of course the Herbalife China approval doesn’t hurt either.
NEW YORK, March 26 (newratings.com) – Analysts at Wedbush Morgan
maintain their "buy" rating on Herbalife Ltd (ticker: HLF), while
raising their estimates for the company. The 12-month target price is
set to $47.In
a research note published this morning, the analysts mention that the
company has received an approval to conduct its direct selling
activities in China. Herbalife continues to raise its marketing
spending on its brand building initiatives in order to improve its name
recognition worldwide, the analysts add. The EPS estimate for 2008 has
been raised from $2.80 to $2.85 to reflect the impact of the direct
selling approval.
